Cisplatin and Fluorouracil Alone or with Docetaxel in Head and Neck CancerMarshall R. Posner, Robert I. Haddad, Diáne Hershock et al.|New England Journal of Medicine|2007Cited by 1.7k
Phase I Studies of Anti–Epidermal Growth Factor Receptor Chimeric Antibody C225 Alone and in Combination With CisplatinJosé Baselga, John Mendelsohn, David G. Pfister et al.|Journal of Clinical Oncology|2000Cited by 746
Activity of XL184 (Cabozantinib), an Oral Tyrosine Kinase Inhibitor, in Patients With Medullary Thyroid CancerRazelle Kurzrock, Ravi Salgia, Douglas W. Ball et al.|Journal of Clinical Oncology|2011Cited by 551
Sequential therapy for the locally advanced larynx and hypopharynx cancer subgroup in TAX 324: survival, surgery, and organ preservationMarshall R. Posner, Robert I. Haddad, Charles M. Norris et al.|Annals of Oncology|2009Cited by 152
Dual checkpoint targeting of B7-H3 and PD-1 with enoblituzumab and pembrolizumab in advanced solid tumors: interim results from a multicenter phase I/II trialCharu Aggarwal, Nehal J. Lakhani, Amy Prawira et al.|Journal for ImmunoTherapy of Cancer|2022Cited by 140